Clinical Trial Update: A Study of JNJ-75220795 in Japanese Participants [Phase 1]

View source ↗

Summary

This clinical trial update reports the termination of a Phase 1 study of JNJ-75220795 in Japanese participants for fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• JNJ-75220795

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Fatty Liver | Phase 1 | Status: TERMINATED